Press Releases

Publications

Bioenergetics breakdown in Alzheimer's disease: targets for new therapies.

    U. Saxena. Int J Physiol Pathophysiol Pharmacol 2011 (in press)

Alzheimer's disease amyloid hypothesis at crossroads: where do we go from here?.

    U. Saxena. Expert Opinion Therapeutic Targets 2010, 14 (12):1273-1277

Is Alzheimer's a lifestyle disease?.

    U. Saxena. Nature India. Published online January 31, 2011.

Lipid metabolism and Alzheimer’s disease: pathways and possibilities.

    U. Saxena. Expert Opin. Ther. Targets. 2009, 13 (3):331-8

Kareus Therapeutics Enters Strategic Alliance With Quintiles.

    La Chaux-de-Fonds, Switzerland, 13 June 2011